[Federal Register Volume 61, Number 181 (Tuesday, September 17, 1996)]
[Rules and Regulations]
[Page 48830]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-23556]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

21 CFR parts 1309, 1310 and 1313

[DEA No. 138F]


Removal of Exemption for Certain Pseudoephedrine Products 
Marketed Under the Food, Drug, and Cosmetic Act (FD&C Act); Correction

AGENCY: Drug Enforcement Administration (DEA), Justice.

ACTION: Correction to final regulations.

-----------------------------------------------------------------------

SUMMARY: This document contains corrections to the final regulations 
which were published on Wednesday, August 7, 1996 (61 FR 40981). The 
regulations related to the removal of the exemption for certain 
pseudoephedrine products marketed under the Food, Drug, and Cosmetic 
Act (FD&C Act).

EFFECTIVE DATE: October 7, 1996.

FOR FURTHER INFORMATION CONTACT:
Frank Sapienza, Acting Chief, Drug and Chemical Evaluation Section, 
Office of Diversion Control, Drug Enforcement Administration, 
Washington, D.C. 20537, Telephone (202) 307-7183.

SUPPLEMENTARY INFORMATION: The final regulations that are the subject 
of these corrections remove the exemption for certain pseudoephedrine 
products marketed under the Food, Drug, and Cosmetic Act (FD&C Act). 
The regulations amend Title 21, Code of Federal Regulations, to revise 
certain sections in Parts 1309, 1310 and 1313.
    The final rule (61 FR 40981) added a new section designated as 
``Section 1309.28''. This new section should have been designated as 
``Section 1309.29''. Therefore, in each instance where the final rule 
refers to the wording ``Section 1309.28'', the reader should substitute 
the wording ``Section 1309.29''.
    Accordingly, the publication on August 7, 1996 of the final 
regulation (61 FR 40981) is corrected as follows:

PART 1309--[CORRECTED]


Sec. 1309.02  [Corrected]

    1. On page 40989 in the second column Sec. 1309.02(f) is corrected 
by removing ``Sec. 1309.28'' and adding ``Sec. 1309.29'' in its place.


Sec. 1309.29  [Corrected]

    2. On page 40989, in the third column, amendatory instruction 3 is 
corrected to read as follows:

``Section 1309.29 is added to read as follows:''
    3. On page 40989, in the third column, the number and heading under 
amendatory instruction 3 are corrected to read as follows:


``Sec. 1309.29  Exemption of retail distributors of certain 
pseudoephedrine products.''

PART 1310--[CORRECTED]


Sec. 1310.04  [Corrected]

    4. On page 40990, Sec. 1310.04, is corrected by removing 
Sec. 1309.28'' and adding ``Sec. 1309.29'' in its place.

    Dated: September 9, 1996.
Stephen H. Greene,
Deputy Administrator, Drug Enforcement Administration.
[FR Doc. 96-23556 Filed 9-16-96; 8:45 am]
BILLING CODE 4410-09-M